CS logo
small CS logo
Instituto Nacional de Enfermedades Respiratorias

Mexico City, Mexico
Specialized hospital in Mexico City
Calz. de Tlalpan 4502, Belisario Domínguez Secc 16, Tlalpan, 14080 Ciudad de México, CDMX

About Instituto Nacional de Enfermedades Respiratorias


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Instituto Nacional de Enfermedades Respiratorias
6
Boehringer Ingelheim
5
Hoffmann-La Roche
5
National Institute of Allergy and Infectious Diseases (NIAID)
5
National Institute of Respiratory Diseases, Mexico
5
Bristol-Myers Squibb
2
Cook Group Incorporated
1
Inmunotek S.L.
1
Instituto Nacional de Cancerologia de Mexico
1
Mexican Emerging Infectious Diseases Clinical Research Network
1
National Institute of Cancerología
1
Total Rows: 16

Clinical Trials at Instituto Nacional de Enfermedades Respiratorias


During the past decade, Instituto Nacional de Enfermedades Respiratorias conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 13 clinical trials were completed, i.e. on average, 56.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 7 clinical trials were completed. i.e. 53.8% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years221144330010103300000033332244Started TrialsCompleted Trails2015201620172018201920202021051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients
2000-06-01
2002-04-01
Completed
730
A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor
2001-08-01
2002-04-01
Terminated
500

Rows per page:

1–38 of 38

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Instituto Nacional de Enfermedades Respiratorias" #1 sponsor was "Instituto Nacional de Enfermedades Respiratorias" with 6 trials, followed by "Boehringer Ingelheim" with 5 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials sponsored and "National Institute of Respiratory Diseases, Mexico" with 5 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Nacional de Enfermedades Respiratorias" #1 collaborator was "American College of Rheumatology" with 1 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 1 trials as a collaborator, "Cook Ireland, Ltd." with 1 trials as a collaborator, "Fundación Clínica Médica Sur" with 1 trials as a collaborator and "Hospital Infantil de Mexico Federico Gomez" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.
Created with Highcharts 11.1.0Top Leading SponsorsInstituto Nacional deEnfermedadesRespiratorias: 6Instituto Nacional deEnfermedadesRespiratorias: 6Boehringer Ingelheim: 5Boehringer Ingelheim: 5Hoffmann-La Roche: 5Hoffmann-La Roche: 5National Institute ofAllergy and InfectiousDiseases (NIAID): 5National Institute ofAllergy and InfectiousDiseases (NIAID): 5National Institute ofRespiratory Diseases,Mexico: 5National Institute ofRespiratory Diseases,Mexico: 5Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Cook Group Incorporated: 1Cook Group Incorporated: 1Inmunotek S.L.: 1Inmunotek S.L.: 1Instituto Nacional deCancerologia deMexico: 1Instituto Nacional deCancerologia deMexico: 1Mexican EmergingInfectious DiseasesClinical ResearchNetwork: 1Mexican EmergingInfectious DiseasesClinical ResearchNetwork: 1

Created with Highcharts 11.1.0Top CollaboratorsAmerican College ofRheumatology: 1American College ofRheumatology: 1Cambridge UniversityHospitals NHSFoundation Trust: 1Cambridge UniversityHospitals NHSFoundation Trust: 1Cook Ireland, Ltd.: 1Cook Ireland, Ltd.: 1Fundación Clínica Médica Sur: 1Fundación Clínica Médica Sur: 1Hospital Infantil deMexico FedericoGomez: 1Hospital Infantil deMexico FedericoGomez: 1Ina-Respond: 1Ina-Respond: 1Institut National deRecherche Biomédicale.Kinshasa, RépubliqueDémocratique duCongo: 1Institut National deRecherche Biomédicale.Kinshasa, RépubliqueDémocratique duCongo: 1Instituto Mexicano delSeguro Social: 1Instituto Mexicano delSeguro Social: 1Instituto Nacional deEnfermedadesRespiratorias: 1Instituto Nacional deEnfermedadesRespiratorias: 1MED Institute, Incorporated: 1MED Institute, Incorporated: 1

Clinical Trials Conditions at Instituto Nacional de Enfermedades Respiratorias


According to Clinical.Site data, the most researched conditions in "Instituto Nacional de Enfermedades Respiratorias" are "COVID-19" (8 trials), "Idiopathic Pulmonary Fibrosis" (4 trials), "Aspirin-exacerbated Respiratory Disease" (2 trials), "COPD" (2 trials) and "Covid19" (2 trials). Many other conditions were trialed in "Instituto Nacional de Enfermedades Respiratorias" in a lesser frequency.

Clinical Trials Intervention Types at Instituto Nacional de Enfermedades Respiratorias


Most popular intervention types in "Instituto Nacional de Enfermedades Respiratorias" are "Drug" (22 trials), "Other" (9 trials), "Procedure" (3 trials), "Device" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Remdesivir" (4 trials), "Nintedanib" (3 trials), "Baricitinib" (2 trials) and "Crizotinib" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Instituto Nacional de Enfermedades Respiratorias


The vast majority of trials in "Instituto Nacional de Enfermedades Respiratorias" are 36 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Instituto Nacional de Enfermedades Respiratorias


Currently, there are NaN active trials in "Instituto Nacional de Enfermedades Respiratorias". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Instituto Nacional de Enfermedades Respiratorias, undefined suspended trials, and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto Nacional de Enfermedades Respiratorias, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 18Phase 3: 18Not Applicable: 7Not Applicable: 7Phase 2: 4Phase 2: 4Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 23Completed: 23Unknown status: 6Unknown status: 6Terminated: 5Terminated: 5Active, not recruiting: 3Active, not recruiting: 3Withdrawn: 1Withdrawn: 1